Cite
MLA Citation
T. Vassilakopoulos et al.. “P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES.” HemaSphere, vol. 6, n.d., pp. 1114–1115. http://access.bl.uk/ark:/81055/vdc_100159755970.0x00000b